That's my main concern (concern for s/c data is mi
Post# of 148110
1) By approving Leronlimab (1st for covid, then HIV, then cancer, then NASH, then MS, then stroke, etc.) will the FDA truly be shifting potentially billions of dollars from established, large, reputable, huge "research tanks" Big Pharma firms, who put billions of dollars into research to discover/create drugs that cure our ills? (Thus, hindering their progress, pulling $$ from their research?)
2) Is the FDA corrupt?
3) Or take it down a step, corruptible?
4) Or take it down a step: influenced by bigpharma?
5) Or take it down a step: is the FDA slowed down to delay our EUA while talking with "buddies and good ole boys" in BP?
6) Do the approvals of Eli Lilly, Regeneron, Plama, Remdesivir for s/c, Remdesivir for m/m, do these FDA EUA approvals support any of the above questions..??